The Lab Automation Market is expected to reach $11.31 billion by 2031, at a CAGR of 7.3% from 2024 to 2031. The growth of this market can be attributed to several factors, including the increasing pharmaceutical and biotech R&D expenditures, the growing demand for automated labs and instruments, the increasing prevalence of chronic and infectious diseases, and government initiatives supporting life sciences R&D. Additionally, growth in genomics & proteomics research, the increasing focus on food safety and quality, rising awareness & growing adoption of personalized medicine, and emerging economies serve as opportunities for the market.
Funding and investments are critical for the lab automation industry in driving innovation, advancing research & development, and improving patient outcomes. Investments come from various sources, such as governments, associations, and venture capitalists. For instance, according to the National Venture Capital Association, venture capital investments and funding for biotech and pharmaceutical companies in the U.S. reached USD 30.7 billion in 2022 from USD 18.7 billion in 2019. Similarly, Merck KgaA (Germany) has a program called the Advance Biotech Grant Program, which is offered to biopharmaceutical, pharmaceutical, start-ups, entrepreneurs, scientists and students in different regions of the world. This program awards products, services, and consultations to the awardees to help accelerate their growth in the market.
Increasing funding and investments are driving the growth of the life sciences industry, boosting the adoption of laboratory automation equipment.
Click here to: Get Free Sample Pages of this Report
Lab automation systems include automated liquid handling systems, automated ELISA systems, automated nucleic acid purification systems, automated storage & retrieval systems, automated microplate readers, and other lab automation systems. The integration of automation systems in laboratories eliminates the need for most repetitive tasks in a lab, such as library preparation or liquid handling, that have typically been performed manually by lab technicians or scientists. Lab automation systems can replace manual, repetitive tasks, increase throughput, and improve quality. The major benefits of lab automation include high efficiency, reproducibility, data accuracy, traceability, safety, and faster speed. There has been an increase in the demand for automated lab instruments due to the need to be interconnected. This coupled with the growing initiatives to support the growth of lab automation in various industries, are factors supporting the market growth.
There have been several technological advancements in the field of laboratory automation, one of which is the use of Artificial Intelligence (AI) and Machine Learning (ML). The reliance of laboratories on AI and ML is increasing rapidly due to the shortage of skilled professionals in laboratories. AI and ML help automate workflows, prioritize samples, differentiate between conditions, verify results, and perform quality checks. In May 2023, A. Menarini Diagnostics Ltd. (U.K.) announced the launch of Prime MDx, a fully automated molecular diagnostics platform. This sample-to-result platform allows users to process a variety of sample types through real-time Polymerase Chain Reaction (PCR). This platform can run up to 5 different assays per sample with a capacity of 240 samples per day using AI-driven software.
Adopting automation and AI can significantly increase the efficiency of laboratories and offer growth opportunities for the lab automation market.
Integrating digital and automation technologies offers better solutions such as enhanced efficiency, accuracy, and real-time data analysis. Several trends such as internet of things (IoT), artificial intelligence (AI), machine learning (ML) can lead to seamless workflow in laboratories. Integrated connectivity provides seamless connectivity, allows the process of samples in less time, better reliability and reproducibility, and fully traceable data.
Several companies are launching new software and solutions to orchestrate scientific discoveries and several new products. For instance, in March 2022, Biosero, Inc. (U.S.) launched new products and solutions in the company’s Green Button Go software suite that is an advanced laboratory automation solution that helps customers streamline, control, and generate better results from the existing automated laboratory systems.
The growing awareness & adoption of personalized medicines are expected to generate growth opportunities for the players operating in the laboratory automation market. The increasing awareness and adoption of personalized medicines are driving the demand for specialized and automated laboratory equipment and technologies that enable precise, error-free, and accurate genetic and molecular analysis. Personalized medicine heavily relies on genetic testing, sequencing, genomic & proteomic information analysis, and biomarker identification and validation, necessitating the use of advanced laboratory equipment, such as DNA sequencers, gene sequencers, PCR machines, real-time PCR systems, next-generation sequencers, mass spectrometers, immunoassay analyzers, and chromatography systems to produce accurate results.
Additionally, with advancements in DNA sequencing technologies and reduced costs, there has been a significant increase in demand for DNA sequencing in genomics research, clinical diagnostics, and personalized medicine. This demand is boosting the need for high-throughput DNA sequencers, sample preparation equipment, and data analysis tools, which is expected to generate growth opportunities for laboratory equipment manufacturers and suppliers.
Based on product, the lab automation market is segmented into systems and software. In 2024, the systems segment is expected to account for the largest share of 71.5% of the market. The main factors contributing to the large market share of this segment are the elimination of repetitive tasks in laboratories, the increasing prevalence of genetic diseases, and the advantages of automated instruments, such as high efficiency, increased throughput, greater accuracy, and reduced manual intervention. The instruments typically used in laboratories to carry out certain procedures are usually larger in size and require manual adjustment. However, in the case of automated systems, these instruments are usually compact and do not require manual intervention for any of the steps. This speeds up the research process and provides precision in the tasks, proving to be an efficient, fast, and accurate method to carry out research, thereby contributing to the growth of the market.
However, the software segment is expected to grow at the fastest CAGR of 7.4% during the forecast period of 2024–2031. With increasing data generation in research, the demand for software such as electronic laboratory notebook (ELN) to electronically document their experiments, including scientific content and observations, instrument results, and attachments from experiments such as spectra, chromatograms and, if appropriate, chemical structures is increasing, driving the market growth.
Based on application, the lab automation market is segmented into drug discovery, clinical diagnostics, genomics & proteomics research, and other applications. In 2024, the drug discovery segment is expected to account for the largest share of 35.5% of the market. The large market share of this segment is attributed to the ability of automated labs to screen large numbers of compounds more rapidly, reduction of human error, and ability to gain more reproducible, consistent results supporting the largest adoption of automated lab equipment for drug discovery applications. Further, rising pharmaceutical R&D expenditure and government initiatives supporting drug discovery and development are also positively impacting the market.
However, the clinical diagnostics segment is expected to grow at the fastest CAGR of 7.8% during the forecast period of 2024–2031. Lab automation in clinical laboratories has been widely adopted to increase accuracy and efficiency and reduce costs and errors. Automation of clinical laboratories can significantly reduce costs and human errors and can positively impact patient outcomes. Additionally, the shortage of skilled laboratory staff also drives the market growth.
Based on end user, the lab automation market is segmented into pharmaceutical & biotechnology companies, hospitals & diagnostic laboratories, research & academic institutes, and other end users. In 2024, the pharmaceutical & biotechnology companies’ segment is expected to account for the largest share of 41.0% of the market. The large market share of this segment is attributed to the high pharmaceutical R&D expenditure, rising demand for new drug discovery and development, growing focus on increasing overall productivity, growing pharmaceutical and biotechnology R&D expenditure, and initiatives by the pharmaceutical and biotechnology companies to expand their research capabilities by opening new research centers. The introduction of new research centers will lead to an increase in the number of experiments conducted. These experiments can be conducted faster and with more accuracy by using automated lab instruments, therefore driving the growth of the market.
In 2024, North America is expected to account for the largest share of 40.8% of the lab automation market, followed by Europe, Asia-Pacific, Latin America, and the Middle East & Africa. The large share of the segment is attributed to factors such as the increasing pharmaceutical R&D expenditure, rising demand for standardization of laboratory processes, growing demand for improved efficiency, accuracy, and productivity in laboratories, and advanced healthcare infrastructure in the region.
Asia-Pacific is slated to register the highest CAGR in the lab automation market during the forecast period. The high market growth in Asia-Pacific is attributed to improving healthcare infrastructure, increasing disposable income, expanding pharmaceutical & biotechnology industry, and increasing pharmaceutical research and government funding. Improvement in healthcare infrastructure, especially in developing countries, leads to reduced costs, improved accuracy, and faster diagnosis. This, coupled with the use of automated instruments, can substantially increase the growth of the market.
The report offers a competitive analysis based on an extensive assessment of the leading players’ product portfolios, geographic presence, and key growth strategies adopted in the last 3–4 years. Some of the key players operating in the lab automation market are Thermo Fisher Scientific, Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Danaher Corporation (U.S.), Revvity, Inc. (U.S.), Agilent Technologies, Inc. (U.S), Waters Corporation (U.S.), Tecan Group Ltd. (Switzerland), F. Hoffmann-La Roche AG (Switzerland), Siemens Healthineers AG (Germany), Abbott Laboratories (U.S.), Becton, Dickinson, and Company (U.S.), Hudson Robotics, Inc. (U.S.), and Hamilton Company (U.S.). As of 2023, Abbott Laboratories (U.S.), Danaher Corporation (U.S.), Hamilton Company (U.S.), Thermo Fisher Scientific Inc. (U.S.), and Siemens Healthineers AG (Germany) collectively hold a share of 47%-49% in the global lab automation market.
In September 2023, Bio-Rad Laboratories, Inc. launched the PTC Tempo 48/48 and PTC Tempo 384 thermal cyclers that are designed to aid PCR applications such as sequencing, cloning, and genotyping.
In February 2023, Revvity, Inc. launched the EnVision Nexus Multimode Microplate Reader, which provides high-throughput screening and accelerates drug discovery results.
|
Particular |
Details |
|
Page No |
244 |
|
Format |
|
|
Forecast Period |
2024-2031 |
|
Base Year |
2023 |
|
CAGR |
7.3% |
|
Market Size (Value) |
$11.31 billion |
|
Market Size (Volume) |
NA |
|
Segments Covered |
By Product
By Application
By End User
|
|
Countries Covered |
North America (U.S., Canada), Europe (Germany, France, U.K., Italy, Spain, RoE), Asia-Pacific (China, Japan, India, RoAPAC), Latin America, and the Middle East & Africa. |
|
Key Companies |
Thermo Fisher Scientific, Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Danaher Corporation (U.S.), Revvity, Inc. (U.S.), Agilent Technologies, Inc. (U.S.), Waters Corporation (U.S.), Tecan Group Ltd. (Switzerland), F. Hoffmann-La Roche AG (Switzerland), Siemens Healthineers AG (Germany), Abbott Laboratories (U.S.), Becton, Dickinson, and Company (U.S.), Hudson Robotics, Inc. (U.S.), Hamilton Company (U.S.) |
This market study covers the market sizes & forecasts of the lab automation based on product, application, end user, and geography. This market study also provides the value analysis of various segments and subsegments of the global lab automation market at country levels.
The global lab automation market is projected to reach $11.31 billion by 2031, at a CAGR of 7.3% during the forecast period.
Based on product, the lab automation market is segmented into systems and software. In 2024, the systems segment is expected to account for the largest share of the market.
Based on application, in 2024, the drug discovery segment is expected to account for the largest share of the market. The large share of the segment is due to the benefits of lab automation in the drug discovery and development process, the ability of automated instruments to screen large numbers of compounds more rapidly, removing human error, enabling more reproducible and consistent results, and the government initiatives supporting the drug discovery and development process.
The growth of this market can be attributed to several factors, including the increasing pharmaceutical and biotech R&D expenditures, the growing demand for automated labs and instruments, the increasing prevalence of chronic and infectious diseases, and government initiatives supporting life sciences R&D. Additionally, growth in genomics & proteomics research, the increasing focus on food safety and quality, rising awareness & growing adoption of personalized medicine, and emerging economies serve as opportunities for the market.
The key players operating in the global lab automation market are Thermo Fisher Scientific, Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Danaher Corporation (U.S.), Revvity, Inc. (U.S.), Agilent Technologies, Inc. (U.S.), Waters Corporation (U.S.), Tecan Group Ltd. (Switzerland), F. Hoffmann-La Roche AG (Switzerland), Siemens Healthineers AG (Switzerland), Abbott Laboratories (U.S.), Becton, Dickinson, and Company (U.S.), Hudson Robotics, Inc. (U.S.), and Hamilton Company (U.S.).
Growing adoption of lab automation in emerging economies such as China and India, factors such as rising healthcare expenditure, increasing focus of governments of different countries to adopt lab automation, and the increasing prevalence of chronic and infectious diseases are the major factors expected to provide growth opportunities for players operating in this market.
This report provides pre & post COVID-19 market estimates.
1. Introduction
1.1. Market Definition & Scope
1.2. Market Ecosystem
1.3. Currency and Limitations
1.4. Key Stakeholders
2. Research Methodology
2.1. Research Approach
2.2. Process of Data Collection & Validation
2.2.1. Secondary Research
2.2.2. Primary Research/Interviews With Key Opinion Leaders From the Industry
2.3. Market Sizing and Forecasting
2.3.1. Market Size Estimation Approach
2.3.2. Growth Forecast Approach
2.3.3. Market Share Analysis
2.4. Assumptions for the Study
3. Executive Summary
4. Market Insights
4.1. Overview
4.2. Factors Affecting Market Growth
4.2.1. Impact Analysis of Market Dynamics
4.3. Factor Analysis
4.4. Regulatory Analysis
4.4.1. Overview
4.4.2. North America
4.4.2.1. U.S.
4.4.2.2. Canada
4.4.3. Europe
4.4.4. Asia-Pacific
4.4.4.1. China
4.4.4.2. Japan
4.4.4.3. India
4.4.5. Latin America
4.4.6. Middle East
4.5. Pricing Analysis
4.6. Industry and Technology Trends
4.6.1. Adoption of Artificial Intelligence (AI) in Laboratory Automation
4.6.2. Growing Demand for Optimized & Streamlined NGS Workflows
4.7. Porter’s Five Forces Analysis
4.7.1. Bargaining Power of Buyers
4.7.2. Bargaining Power of Suppliers
4.7.3. Threat of Substitutes
4.7.4. Threat of New Entrants
4.7.5. Degree of Competition
5. Lab Automation Market Assessment—by Product
5.1. Overview
5.2. Systems
5.2.1. Automated Liquid Handling Systems
5.2.2. Automated ELISA Systems
5.2.3. Automated Nucleic Acid Purification Systems
5.2.4. Automated Microplate Readers
5.2.5. Automated Storage and Retrieval Systems
5.2.6. Other Systems
5.3. Lab Automation Software
5.3.1. Workstation/Equipment Automation Software
5.3.2. Laboratory Information Management System (LIMS)
5.3.3. Electronic Lab Notebook (ELN)
5.3.4. Scientific Data Management Systems (SDMS)
6. Lab Automation Market Assessment—by Application
6.1. Overview
6.2. Drug Discovery
6.3. Clinical Diagnostics
6.4. Genomics & Proteomics Research
6.5. Other Applications
7. Lab Automation Market Assessment—by End User
7.1. Overview
7.2. Pharmaceutical and Biotechnology Companies
7.3. Hospitals and Diagnostic Laboratories
7.4. Research & Academic Institutes
7.5. Other End Users
8. Lab Automation Market Assessment—by Geography
8.1. Overview
8.2. North America
8.2.1. U.S.
8.2.2. Canada
8.3. Europe
8.3.1. Germany
8.3.2. France
8.3.3. U.K.
8.3.4. Italy
8.3.5. Spain
8.3.6. Rest of Europe
8.4. Asia-Pacific
8.4.1. China
8.4.2. Japan
8.4.3. India
8.4.4. Rest of Asia-Pacific
8.5. Latin America
8.6. Middle East & Africa
9. Competition Analysis
9.1. Overview
9.2. Key Growth Strategies
9.3. Competitive Benchmarking
9.4. Competitive Dashboard
9.4.1. Industry Leaders
9.4.2. Market Differentiators
9.4.3. Vanguards
9.4.4. Emerging Companies
9.5. Market Share Analysis (2022)
9.5.1. Abbott Laboratories (U.S.)
9.5.2. Danaher Corporation (U.S.)
9.5.3. Hamilton Company (U.S.)
9.5.4. Thermo Fisher Scientific, inc. (U.S.)
9.5.5. Siemens Healthineers AG (Germany)
10. Company Profiles (Business Overview, Financial Overview, Product Portfolio, and Strategic Developments)
10.1. Abbott Laboratories
10.2. Danaher Corporation
10.3. Hamilton Company
10.4. Siemens Healthineers Ag
10.5. Thermo Fisher Scientific, inc.
10.6. F. Hoffmann-La Roche Ag
10.7. Agilent Technologies, inc.
10.8. Revvity, inc. (Formerly Known As PerkinElmer, inc.)
10.9. Bio-Rad Laboratories, inc.
10.10. Becton, Dickinson, and Company
10.11. Tecan Group Ltd.
10.12. Waters Corporation
10.13. Hudson Robotics, inc.
(Note: SWOT Analysis of the Top 5 Companies Will Be Provided)
11. Appendix
11.1. Available Customization
11.2. Related Reports
List of Tables
Table 1 Important ISO Standards for the Laboratory Automation Industry
Table 2 Key FDA Regulations Governing Lab Automation Products
Table 3 India: Laws Regulating the Life Sciences Industry
Table 4 Lab Automation Instruments & Systems: Pricing Details
Table 5 Lab Automation Software: Pricing Details
Table 6 Automated NGS Workstations: Pricing Details
Table 7 Global Lab Automation Market, by Product, 2022–2031 (USD Million)
Table 8 Global Lab Automation Market, by System, 2022–2031 (USD Million)
Table 9 Global Lab Automation Systems Market, by Country/Region, 2022–2031 (USD Million)
Table 10 Global Automated Liquid Handling Systems Market, by Country/Region, 2022–2031 (USD Million)
Table 11 Type of Automated ELISA Systems
Table 12 Global Automated ELISA Systems Market, by Country/Region, 2022–2031 (USD Million)
Table 13 Global Automated Nucleic Acid Purification Systems Market, by Country/Region, 2022–2031 (USD Million)
Table 14 Recent Advancements in Microplate Reader Technology
Table 15 Global Automated Microplate Readers Market, by Country/Region, 2022–2031 (USD Million)
Table 16 Advantages of Automated Storage and Retrieval Systems in Laboratory Automation
Table 17 Global Automated Storage and Retrieval Systems Market, by Country/Region, 2022–2031 (USD Million)
Table 18 Global Other Lab Automation Systems Market, by Country/Region, 2022–2031 (USD Million)
Table 19 Global Lab Automation Software Market, by Type, 2022–2031 (USD Million)
Table 20 Global Lab Automation Software Market, by Country/Region, 2022–2031 (USD Million)
Table 21 Examples of Lab Automation Software
Table 22 Global Workstation/Equipment Automation Software Market, by Country/Region, 2022–2031 (USD Million)
Table 23 Global Laboratory Information Management System (LIMS) Market, by Country/Region, 2022–2031 (USD Million)
Table 24 Global Electronic Lab Notebook (ELN) Market, by Country/Region, 2022–2031 (USD Million)
Table 25 Global Scientific Data Management System (SDMS) Market, by Country/Region, 2022–2031 (USD Million)
Table 26 Global Lab Automation Market, by Application, 2022–2031 (USD Million)
Table 27 Global Lab Automation Market for Drug Discovery, by Country/Region, 2022–2031 (USD Million)
Table 28 Global Lab Automation Market for Clinical Diagnostics, by Country/Region, 2022–2031 (USD Million)
Table 29 Global Lab Automation Market for Genomics & Proteomics Research, by Country/Region, 2022–2031 (USD Million)
Table 30 Global Lab Automation Market for Other Applications, by Country/Region, 2022–2031 (USD Million)
Table 31 Global Lab Automation Market, by End User, 2022–2031 (USD Million)
Table 32 Global Lab Automation Market for Pharmaceutical and Biotechnology Companies, by Country/Region, 2022–2031 (USD Million)
Table 33 Global Lab Automation Market for Hospitals and Diagnostic Laboratories, by Country/Region, 2022–2031 (USD Million)
Table 34 Global Lab Automation Market for Research & Academic Institutes, by Country/Region, 2022–2031 (USD Million)
Table 35 Global Lab Automation Market for Other End Users, by Country/Region, 2022–2031 (USD Million)
Table 36 Global Lab Automation Market, by Country/Region, 2022–2031 (USD Million)
Table 37 North America: Lab Automation Market, by Country, 2022–2031 (USD Million)
Table 38 North America: Lab Automation Market, by Product, 2022–2031 (USD Million)
Table 39 North America: Lab Automation Systems Market, by Type, 2022–2031 (USD Million)
Table 40 North America: Lab Automation Software Market, by Type, 2022–2031 (USD Million)
Table 41 North America: Lab Automation Market, by Application, 2022–2031 (USD Million)
Table 42 North America: Lab Automation Market, by End User, 2022–2031 (USD Million)
Table 43 U.S.: Key Macro & Micro indicators
Table 44 U.S.: Lab Automation Market, by Product, 2022–2031 (USD Million)
Table 45 U.S.: Lab Automation Systems Market, by Type, 2022–2031 (USD Million)
Table 46 U.S.: Lab Automation Software Market, by Type, 2022–2031 (USD Million)
Table 47 U.S.: Lab Automation Market, by Application, 2022–2031 (USD Million)
Table 48 U.S.: Lab Automation Market, by End User, 2022–2031 (USD Million)
Table 49 Canada: Key Macro & Micro indicators
Table 50 Canada: Lab Automation Market, by Product, 2022–2031 (USD Million)
Table 51 Canada: Lab Automation Systems Market, by Type, 2022–2031 (USD Million)
Table 52 Canada: Lab Automation Software Market, by Type, 2022–2031 (USD Million)
Table 53 Canada: Lab Automation Market, by Application, 2022–2031 (USD Million)
Table 54 Canada: Lab Automation Market, by End User, 2022–2031 (USD Million)
Table 55 Europe: Lab Automation Market, by Country/Region, 2022–2031 (USD Million)
Table 56 Europe: Lab Automation Market, by Product, 2022–2031 (USD Million)
Table 57 Europe: Lab Automation Systems Market, by Type, 2022–2031 (USD Million)
Table 58 Europe: Lab Automation Software Market, by Type, 2022–2031 (USD Million)
Table 59 Europe: Lab Automation Market, by Application, 2022–2031 (USD Million)
Table 60 Europe: Lab Automation Market, by End User, 2022–2031 (USD Million)
Table 61 Germany: Key Macro & Micro indicators
Table 62 Germany: Lab Automation Market, by Product, 2022–2031 (USD Million)
Table 63 Germany: Lab Automation Market Systems Market, by Type, 2022–2031 (USD Million)
Table 64 Germany: Lab Automation Software Market, by Type, 2022–2031 (USD Million)
Table 65 Germany: Lab Automation Market, by Application, 2022–2031 (USD Million)
Table 66 Germany: Lab Automation Market, by End User, 2022–2031 (USD Million)
Table 67 France: Key Macro & indicators
Table 68 France: Lab Automation Market, by Product, 2022–2031 (USD Million)
Table 69 France: Lab Automation Systems Market, by Type, 2022–2031 (USD Million)
Table 70 France: Lab Automation Software Market, by Type, 2022–2031 (USD Million)
Table 71 France: Lab Automation Market, by Application, 2022–2031 (USD Million)
Table 72 France: Lab Automation Market, by End User, 2022–2031 (USD Million)
Table 73 U.K.: Key Macro & Micro indicators
Table 74 U.K.: Lab Automation Market, by Product, 2022–2031 (USD Million)
Table 75 U.K.: Lab Automation Systems Market, by Type, 2022–2031 (USD Million)
Table 76 U.K.: Lab Automation Software Market, by Type, 2022–2031 (USD Million)
Table 77 U.K.: Lab Automation Market, by Application, 2022–2031 (USD Million)
Table 78 U.K.: Lab Automation Market, by End User, 2022–2031 (USD Million)
Table 79 Italy: Key Macro & Micro indicators
Table 80 Italy: Lab Automation Market, by Product, 2022–2031 (USD Million)
Table 81 Italy: Lab Automation Systems Market, by Type, 2022–2031 (USD Million)
Table 82 Italy: Lab Automation Software Market, by Type, 2022–2031 (USD Million)
Table 83 Italy: Lab Automation Market, by Application, 2022–2031 (USD Million)
Table 84 Italy: Lab Automation Market, by End User, 2022–2031 (USD Million)
Table 85 Spain: Key Macro & Micro indicators
Table 86 Spain: Lab Automation Market, by Product, 2022–2031 (USD Million)
Table 87 Spain: Lab Automation Systems Market, by Type, 2022–2031 (USD Million)
Table 88 Spain: Lab Automation Software Market, by Type, 2022–2031 (USD Million)
Table 89 Spain: Lab Automation Market, by Application, 2022–2031 (USD Million)
Table 90 Spain: Lab Automation Market, by End User, 2022–2031 (USD Million)
Table 91 Estimated Number of New Cancer Cases, by Country, 2020 Vs. 2030
Table 92 Rest of Europe: Lab Automation Market, by Product, 2022–2031 (USD Million)
Table 93 Rest of Europe: Lab Automation Systems Market, by Type, 2022–2031 (USD Million)
Table 94 Rest of Europe: Lab Automation Software Market, by Type, 2022–2031 (USD Million)
Table 95 Rest of Europe: Lab Automation Market, by Application, 2022–2031 (USD Million)
Table 96 Rest of Europe: Lab Automation Market, by End User, 2022–2031 (USD Million)
Table 97 Asia-Pacific: Lab Automation Market, by Country, 2022–2031 (USD Million)
Table 98 Asia-Pacific: Lab Automation Market, by Product, 2022–2031 (USD Million)
Table 99 Asia-Pacific: Lab Automation Systems Market, by Type, 2022–2031 (USD Million)
Table 100 Asia-Pacific: Lab Automation Software Market, by Type, 2022–2031 (USD Million)
Table 101 Asia-Pacific: Lab Automation Market, by Application, 2022–2031 (USD Million)
Table 102 Asia-Pacific: Lab Automation Market, by End User, 2022–2031 (USD Million)
Table 103 China: Key Macro & Micro indicators
Table 104 China: Lab Automation Market, by Product, 2022–2031 (USD Million)
Table 105 China: Lab Automation Systems Market, by Type, 2022–2031 (USD Million)
Table 106 China: Lab Automation Software Market, by Type, 2022–2031 (USD Million)
Table 107 China: Lab Automation Market, by Application, 2022–2031 (USD Million)
Table 108 China: Lab Automation Market, by End User, 2022–2031 (USD Million)
Table 109 Japan: Key Macro & Micro indicators
Table 110 Japan: Lab Automation Market, by Product, 2022–2031 (USD Million)
Table 111 Japan: Lab Automation Systems Market, by Type, 2022–2031 (USD Million)
Table 112 Japan: Lab Automation Software Market, by Type, 2022–2031 (USD Million)
Table 113 Japan: Lab Automation Market, by Application, 2022–2031 (USD Million)
Table 114 Japan: Lab Automation Market, by End User, 2022–2031 (USD Million)
Table 115 India: Key Macro & Micro indicators
Table 116 India: Lab Automation Market, by Product, 2022–2031 (USD Million)
Table 117 India: Lab Automation Systems Market, by Type, 2022–2031 (USD Million)
Table 118 India: Lab Automation Software Market, by Type, 2022–2031 (USD Million)
Table 119 India: Lab Automation Market, by Application, 2022–2031 (USD Million)
Table 120 India: Lab Automation Market, by End User, 2022–2031 (USD Million)
Table 121 Estimated Number of New Cancer Cases, by Country, 2020 Vs. 2030
Table 122 Rest of Asia-Pacific: Lab Automation Market, by Product, 2022–2031 (USD Million)
Table 123 Rest of Asia-Pacific: Lab Automation Systems Market, by Type, 2022–2031 (USD Million)
Table 124 Rest of Asia-Pacific: Lab Automation Software Market, by Type, 2022–2031 (USD Million)
Table 125 Rest of Asia-Pacific: Lab Automation Market, by Application, 2022–2031 (USD Million)
Table 126 Rest of Asia-Pacific: Lab Automation Market, by End User, 2022–2031 (USD Million)
Table 127 Latin America: Lab Automation Market, by Product, 2022–2031 (USD Million)
Table 128 Latin America: Lab Automation Systems Market, by Type, 2022–2031 (USD Million)
Table 129 Latin America: Lab Automation Software Market, by Type, 2022–2031 (USD Million)
Table 130 Latin America: Lab Automation Market, by Application, 2022–2031 (USD Million)
Table 131 Latin America: Lab Automation Market, by End User, 2022–2031 (USD Million)
Table 132 Middle East & Africa: Lab Automation Market, by Product, 2022–2031 (USD Million)
Table 133 Middle East & Africa: Lab Automation Systems Market, by Type, 2022–2031 (USD Million)
Table 134 Middle East & Africa: Lab Automation Software Market, by Type, 2022–2031 (USD Million)
Table 135 Middle East & Africa: Lab Automation Market, by Application, 2022–2031 (USD Million)
Table 136 Middle East & Africa: Lab Automation Market, by End User, 2022–2031 (USD Million)
Table 137 Recent Developments, by Company, 2021–2024
List of Figures
Figure 1 Research Process
Figure 2 Secondary Sources Referenced for This Study
Figure 3 Primary Research Techniques
Figure 4 Key Executives interviewed
Figure 5 Breakdown of Primary interviews (Supply-Side & Demand-Side)
Figure 6 Market Sizing and Growth Forecast Approach
Figure 7 Global Lab Automation Market, by Product, 2024 Vs. 2031 (USD Million)
Figure 8 Global Lab Automation Market, by Application, 2024 Vs. 2031 (USD Million)
Figure 9 Global Lab Market, by End User, 2024 Vs. 2031 (USD Million)
Figure 10 Lab Automation Market Size, by Geography
Figure 11 Global Lab Automation Market: Impact Analysis of Market Drivers, Restraints, Opportunities, and Challenges (2024–2031)
Figure 12 Pharmaceutical R&D Expenditures in the U.S., Europe, and China, 2010 Vs. 2019 Vs. 2020 (USD Million)
Figure 13 Global Pharmaceutical R&D Expenditure, 2016–2028 (USD Billion)
Figure 14 National Institutes of Health (NIH) Annual Budgets, 2016–2022 (USD Billion)
Figure 15 China: Medical Device Classification and Premarket Requirements for IVD Devices
Figure 16 Porter's Five Forces Analysis
Figure 17 Global Lab Automation Market, by Product, 2024 Vs. 2031 (USD Million)
Figure 18 Advantages of Using Automated ELISA Systems
Figure 19 Global Lab Automation Market, by Application, 2024 Vs. 2031 (USD Million)
Figure 20 Global Pharmaceutical R&D Expenditure, 2016–2028 (USD Billion)
Figure 21 Global Drug R&D Pipeline Size (2015–2022)
Figure 22 Number of New Cancer Cases Globally (2020-2040)
Figure 23 Global Lab Automation Market, by End User, 2024 Vs. 2031 (USD Million)
Figure 24 Global Pharmaceutical R&D Expenditure, 2016–2028 (USD Billion)
Figure 25 National Institutes of Health (NIH) Annual Budgets, 2016–2022 (USD Billion)
Figure 26 Global Lab Automation Market Assessment, by Country/Region, 2024 Vs. 2031 (USD Million)
Figure 27 North America: Lab Automation Market Snapshot
Figure 28 Pharmaceutical R&D Expenditure in the U.S. (2000-2020)
Figure 29 Europe: Lab Automation Market Snapshot
Figure 30 Rest of Europe: Pharmaceutical R&D Expenditure
Figure 31 Asia-Pacific: Lab Automation Market Snapshot
Figure 32 China: Pharmaceutical industry R&D Expenditure (2001 Vs. 2010 Vs 2019 Vs. 2020)
Figure 33 Japan: Share of Geriatric Population in Total Population (65 and Over)
Figure 34 Key Growth Strategies Adopted by Leading Players 2021-2024
Figure 35 Lab Automation Market: Competitive Benchmarking by Product Type
Figure 36 Lab Automation Market: Competitive Benchmarking, by Region
Figure 37 Competitive Dashboard: Lab Automation Market
Figure 38 Global Lab Automation Market Share Analysis, by Key Players (2023)
Figure 39 Abbott Laboratories: Financial Overview (2023)
Figure 40 Danaher Corporation: Financial Overview (2023)
Figure 41 Siemens Healthineers AG: Financial Overview (2023)
Figure 42 Thermo Fisher Scientific, inc.: Financial Overview (2023)
Figure 43 F. Hoffmann-La Roche AG: Financial Overview (2023)
Figure 44 Agilent Technologies, inc.: Financial Overview (2023)
Figure 45 Revvity, inc.: Financial Overview (2023)
Figure 46 Bio-Rad Laboratories, inc.: Financial Overview (2023)
Figure 47 Becton, Dickinson, and Company: Financial Overview (2023)
Figure 48 Tecan Group Ltd.: Financial Overview (2023)
Figure 49 Waters Corporation: Financial Overview (2023)
This report provides pre & post COVID-19 market estimates.
This report provides pre & post COVID-19 market estimates.
Published Date: Jan-2024
Published Date: Oct-2023
Published Date: Jun-2022
Published Date: Feb-2022
Published Date: Oct-2023
